ASCP Introduces Age-Friendly Pharmacy (AFP) Recognition
ALEXANDRIA, VA / ACCESS Newswire / October 24, 2025 / ASCP has introduced a new Age-Friendly Pharmacy (AFP) recognition, designed...
Healthcare
Dental Materials and Implant Systems in Istanbul: What Patients Should Know (2025)
ISTANBUL, TURKEY / ACCESS Newswire / October 24, 2025 / Istanbul has rapidly become a global destination for dental implant...
HCA Healthcare Reports Third Quarter 2025 Results
Raises 2025 GuidanceNASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the third quarter ended...
Tutor.com Honored with 2025 CODiE Award for Best Customer Experience Solution for Education
NEW YORK, Oct. 24, 2025 /PRNewswire/ -- Tutor.com, a leading innovator in online tutoring and education solutions, today announced that...
The Craneware Group Announces Full Trisus® Portfolio Co-Sell-Ready and Available in the Microsoft Azure Marketplace
Microsoft Azure customers worldwide can now access The Craneware Group's full portfolio of co-sell-ready Trisus® SaaS solutions, leveraging the scalability,...
Terumo Interventional Systems Announces Its New OPUSWAVE® Dual Sensor Imaging System and DualView® Imaging Catheter Receive FDA 510(k) Clearance
OPUSWAVE Imaging System combines OFDI and IVUS into a single catheter, providing significant potential to reduce procedural time and costs...
Weekly Recap: 12 Tech Press Releases You Need to See
A roundup of the most newsworthy tech announcements from PR Newswire this week, including the release of VERA-MH by Spring Health...
Medical Care Technologies Inc. (OTC PINK:MDCE) Approved as Official Apple Developer
Company advances digital technology initiatives with approval to publish applications on Apple's App Store MESA, ARIZONA / ACCESS Newswire /...
Interactive Strength Inc. (NASDAQ: TRNR) to Release Third-Quarter Results on Friday, November 14, 2025
AUSTIN, TEXAS / ACCESS Newswire / October 24, 2025 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of...
MIRA Pharmaceuticals Initiates Multiple Ascending Dose (MAD) Phase 1 Study of Oral Ketamir-2 and Selects Chemotherapy-Induced Neuropathic Pain as Lead Phase 2a Indication
Advancing toward Phase 2a clinical evaluation in chemotherapy-related pain, a condition with no approved treatments and potential for FDA Fast...
TREMFYA® (guselkumab) receives European Commission approval for subcutaneous induction through to maintenance in adults with ulcerative colitis, now the first IL-23 inhibitor with a fully subcutaneous dose regimen
Guselkumab offers the flexibility of self-administration from the start of treatment in both ulcerative colitis (UC) and Crohn’s disease (CD),1,2,3...
NeurAxis Awarded First Ever FDA Clearance for the Treatment of Pain in Functional Dyspepsia (FD) with associated Nausea Symptoms in the Adult Patient Population
Achieves significant expansion of NeurAxis’ total addressable marketClearance now includes patients aged “8 years and older”Expanded age indication will utilize...
HealthLynked Launches New MedOfficeDirect Shopify Platform at DiscountOnlineMedicalSupplies.com with Improved Performance and Lower Prices
NAPLES, Fla., Oct. 24, 2025 (GLOBE NEWSWIRE) -- via IBN -- HealthLynked Corp. (OTCQB: HLYK), a leading provider of healthcare...
ProPhase Labs to Present at the 2025 ThinkEquity Conference
UNIONDALE, NY, Oct. 24, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (the “Company” or “ProPhase”), a next generation...
Biogen Licenses Oral C5aR1 Antagonist from Vanqua Bio to Expand Immunology Portfolio
The oral C5aR1 antagonist is designed to modulate neutrophil-driven inflammation, a central mechanism underlying many inflammatory diseases CAMBRIDGE, Mass. and...
New Analysis of 13,560 Patients Demonstrates DecisionDx®-Melanoma Stratifies Risk Across Histological Subtypes; Findings to be Presented at Fall Clinical Dermatology Conference
This new histological subtype data confirms DecisionDx-Melanoma’s clinical value across the spectrum of melanoma Castle Biosciences will also present validation...
Polpharma Group Announces Leadership Transition – Sebastian Szymanek appointed as its new President
AMSTERDAM, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Polpharma Group, one of the largest pharmaceutical groups operating across Central and Eastern...
Avextra Supports Phase II Clinical Trial in Italy on Cannabis-based medicines for Neurodegenerative Diseases
First patient enrolled in randomized, placebo-controlled study Bensheim, 24. October 2025 – Neurodegenerative diseases represent one of the biggest challenges...
ONWARD Medical Successfully Raises Over EUR 50 Million in Capital Increase
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY...
Pheton Holdings Ltd Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Beijing, China, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (NASDAQ: PTHL) (the “Company”), a healthcare solution provider specializing...